31
Jul
A medicine meant to treat coeliac disease, an autoimmune ailment mostly affecting the small intestine, has showed potential for infants suffering from severe post-Covid syndrome, according to a small research. Covid infection, albeit uncommon in children, causes multisystem inflammatory syndrome (MIS-C), a dangerous illness characterized by high fevers, gastrointestinal symptoms, and potentially fatal heart damage. The research results, published in the journal Science Translational Medicine, demonstrated that larazotide helped children resume to regular activities more quickly after Covid. "While our study is small, its results are powerful and have implications not only for MIS-C, but potentially for long-term Covid," said…
